"Safe" Investors Who Don't Get Out of Cash NOW Could Lose Everything Over the Next Six Months

The next six months are going to be some of the most precarious times to invest in the history of the United States. Because for the first time, your money is at risk of being completely wiped out, even when you think it is safest. This bubble is on a schedule and to get out before your portfolio becomes shark bait, you need to...

Oil = Monthly Income

Popular

Michelle Yeoh to join business and political leaders at Global Citizen NOW summit to fight poverty

NEW YORK (AP) — Oscar winner Michelle Yeoh, Botswana President Mokgweetsi Masisi, and Verizon CEO Hans Vestberg are among the diverse group of political, business and philanthropic leaders Global Citizen will convene in New York on May 1 and 2, the nonprofit announced on Thursday.

Dairy cattle in Texas and Kansas have tested positive for bird flu

Milk from dairy cows in Texas and Kansas has tested positive for , U.S. officials said Monday.

Super-Billionaire Goes All-in on $3 A.I. Stock - Ad

I've been pounding the table on this $3 A.I. stock for weeks now. I believe we'll soon talk about this little-known stock in the same way we talk about Amazon, Tesla, and Nvidia now. This is without a doubt my #1 recommendation to buy today.

Georgia teachers and state employees will get pay raises as state budget passes

ATLANTA (AP) — Pay raises for Georgia's public school teachers and state employees were never in doubt politically from the moment Gov. Brian Kemp proposed them, but lawmakers finally clinched the deal on Thursday, passing a budget that also boosts spending on education, health care and mental health.

What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?

Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca challenges Arkansas law extending drug discounts to for-profit pharmacy chains, citing federal regulations."

$25 Stock to Fuel the AI Market Boom of 2024 - Ad

One secretive company's new technology is poised to disrupt the AI market -- a market that is projected to grow from roughly $500 billion to $200 trillion. That's a surge of 39,900% over the next six years. Today, you can invest in this one-of-a-kind company for just $25 a share.

Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly

Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its potential to preserve muscle mass, boost metabolism, and induce weight loss.

Supreme Court again confronts the issue of abortion, this time over access to widely used medication

WASHINGTON (AP) — The Supreme Court will again wade into the fractious issue of abortion this week when it hears arguments over , a case with profound implications for millions of women no matter where they live in America and, perhaps, for the race for the White House.

The World's First "$20 Trillion Drug?" - Ad

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Elon Musk Celebrates As Neuralink Patient Makes Historic Post On X Using Nothing But Thoughts

Elon Musk celebrated the "first ever post" using the Neuralink Telepathy implant, made by its first patient, Noland Arbaugh.

How Are Obesity Drugs And Nvidia Related? Success Of Ozempic, Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development

Novo Nordisk Foundation partners with Eviden and Nvidia to pioneer AI-driven healthcare solutions. Expect the Gefion supercomputer to revolutionize drug discovery, supported by tech giants and the Novo Nordisk Foundation.

The No. 1 Crypto for 2024 - Ad

We're entering the final crypto bull run, and 2024 will be your last chance to ever get rich from crypto. These five tiny cryptos are believed to create generational wealth over the next 12 months. $30 trillion is poised to funnel into the crypto markets thanks to a new government regulation just signed.

Why are striking doctors in South Korea facing license suspensions and what’s next?

SEOUL, South Korea (AP) — South Korea is poised to the licenses of thousands of striking junior doctors as a punitive measure against their weekslong walkouts that have shaken hospital operations.

Requiring ugly images of smoking's harm on cigarettes won't breach First Amendment, court says

NEW ORLEANS (AP) — A federal requirement that and advertising include graphic images demonstrating the effects of smoking — including pictures of smoke-damaged lungs and feet blackened by diminished blood flow — does not violate the First Amendment, an appeals court ruled Thursday.

2,000,000 "A.I. Crown Jewels" Set for Mass Production - Ad

A.I. investors...get ready: Because this little-known supplier just received a GIGANTIC order from Nvidia. It's one of the biggest production runs in technology history. And it's part of the reason why Barrons says this supplier could see $100 BILLION in sales by 2025.

FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns

BD boosts U.S. production of medical syringes following FDA concerns over Chinese-made syringes. Learn how BD addresses patient care continuity amid ongoing quality probe.

Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month

GSK caps asthma and COPD medicine costs at $35/month, effective Jan 1, 2025. Includes Advair, Breo, Ventolin. Follows AstraZeneca's suit for their respiratory medicines. Sanders applauds move amid Senate scrutiny over high U.S. inhaler prices.

His System Isolated Nvidia -- Here's His NEXT Buy - Ad

Marc Chaikin's stock-picking system isolated Nvidia before its massive bull run this year. Now, it just flashed "BUY" on a new AI company that no one is talking about yet. It's not a household name... but Marc predicts it could quickly double or triple from here.

Highlights from the AP's reporting on the shrimp industry in India

SAN FRANCISCO (AP) — India is the top supplier of shrimp to the U.S., with Indian shrimp stocked in freezers at most of the nation’s biggest grocery store and restaurant chains.

Dutch court says the government must do more to rein in noise pollution at Amsterdam's busy airport

THE HAGUE, Netherlands (AP) — The Dutch government has systematically put the interests of the aviation sector above those of people who live near Schiphol Airport, one of Europe's busiest aviation hubs, a Dutch court ruled Wednesday, saying that the treatment of local residents amounts to a breach of Europe's human rights convention.

The Sneaky (Yet 100% Legal) Way for Obama to Return to Power - Ad

The ONLY way Democrats can keep the White House is to bring back Barack Obama. And there's a sneaky (yet 100% legal) way to achieve this. In fact, this disaster scenario is already underway. See what they're up to, and how you can get ready today.

An AI robot is spotting sick tulips to slow the spread of disease through Dutch bulb fields

NOORDWIJKERHOUT, Netherlands (AP) — Theo works weekdays, weekends and nights and never complains about a sore spine despite performing hour upon hour of what, for a regular farm hand, would be backbreaking labor checking Dutch tulip fields for sick flowers.

UnitedHealth says it has made progress on recovering from a massive cyberattack

UnitedHealth is testing the last major system it must restore from last month’s , but it has no date yet for finishing the recovery.

CRITICAL May 1st Warning - Ad

Jason Bodner is going public today with an urgent new warning. He believes the most popular investment of 2024 is set to pop... And it could all start just days from now. This has NOTHING to do with A.I. stocks... It has NOTHING to do with crypto currency... And it has NOTHING to do with high-flying tech stocks. Instead, this corner of the market you likely have cash parked in has swelled to nearly $6 trillion.

From Frenchies to rescue cats, New York's trauma center for animals takes the most complex cases

NEW YORK (AP) — Waddling in with lime-green booties on his front paws, Harrison, a beloved seven-year-old , is a familiar sight at the Schwarzman Animal Medical Center in New York City.

What's Going On With Abbott Laboratories Stock On Friday?

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about NEC risks. Over 400 NEC lawsuits pending in federal court in Chicago.

Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad

Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.

Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts

Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts to legal action over Grail acquisition.

Billionaire Tech Investor - How He Got Rich - Ad

He's already made gains of 200,000% ... 499,000% ... and even 3,250,000% on tech startups over the last two decades. Now, he's invested in a stock few people have heard of, which is trading for just $25 a share. See how you can invest alongside him (but you'll want to do it between now and May 5th.

Biden Administration Pressures UnitedHealth for Immediate Action On Cyberattack Fallout

Amid a national health payment crisis, Biden administration officials urge UnitedHealth and industry leaders to stabilize the U.S. health system. Cyberattack fallout threatens vital care delivery."

The Gold Rush Is Back As It Nears ALL Time High - Ad

Gold stocks, including mining companies, ETFs, and royalty firms, offer investors varied exposure to the yellow metal's further potential after hitting a record high in 2023. With a growing portfolio and an experienced management, this natural resource company may be one of the most strategic entrances into the Bullion Boom.

Biden is issuing a budget plan that details his vision for a second term

WASHINGTON (AP) — is issuing a budget plan Monday aimed at getting voters' attention: tax breaks for families, lower health care costs, smaller deficits and higher taxes on the wealthy and corporations.

Insurer delays and denials hamper patients seeking at-home breathing machines

Lou Gehrig’s disease took away Grace Armant’s ability to speak, but the 84-year-old still has plenty to say about her insurance.

This Is Where the World's Richest Men Are Putting Their Money - Ad

Bill Gates, Peter Thiel, Mark Zuckerberg -- they're pouring millions into something we call Imperium technology. And you can invest in this tech alongside them starting with just $10. Bill Gates called Imperium "one of the most powerful technologies of the 21st century."

ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer

ALX Oncology's evorpacept, poised for pivotal HER2+ gastric cancer development. Caution prevails due to sub-$100 million market size; await additional plans backed by phase 1/2 data.

Maker of much-debated ALS drug says it may stop selling it after study showed it didn't work

WASHINGTON (AP) — The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service